# HYDROCODONE BITARTRATE AND ACETAMINOPHEN
> **ANDA201295** · Abbreviated New Drug Application (Generic) · Sponsor: TRIS PHARMA INC · Approved 2021-12-30
## Drug
- **FDA Application Number:** ANDA201295
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- **Generic name:** HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- **Active ingredients:** ACETAMINOPHEN; HYDROCODONE BITARTRATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TRIS PHARMA INC
- **Manufacturer:** Cranbury Pharmaceuticals, LLC
- **First approval:** 2021-12-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201295)
---
*MORVS · CC0 1.0*